source
- BeOne invests $300 million in New Jersey plant, adding small-molecule capacity and 120 jobsBeOne Medicines announced a $300 million investment to expand its manufacturing campus in Hopewell, New Jersey. The expansion will include a three‑story, 145,000‑square‑foot building for small‑mol…
- Roche says its late-stage pipeline is full, sees growth through 2030Roche's CEO Thomas Schinecker told analysts that the company has 19 investigational medicines that could launch by 2030, indicating a robust late-stage pipeline. He added that the depth of the pip…